E2F3 and breast carcinoma: Our own studies using an orthotopic model of breast cancer showed that rescuing back centrosome amplification in Her2+ breast cancer cells silenced for E2F3 through the overexpression of GFP-Nek2 did not influence tumor growth or tumor burden[150].